Vaccines, antibodies, proteins, glycoproteins, DNAs and RNAs for prophylaxis and treatment of Cryptosporidium parvum infections

US6015882A · kind A · utility

Assignee

• The Regents of the University of California · US

Inventors

• Carolyn Petersen · Berkeley, US
• James Leech · South River, US
• Richard C. Nelson · San Francisco, US
• Jiri Gut · Novato, US

Key dates

• Filing date: Aug 14, 1996
• Grant date: Jan 18, 2000
• Expiry date: Aug 14, 2016

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Vaccines, antibodies, proteins, glycoproteins, DNAs and RNAs useful for passive or active prophylaxis and treatment of Cryptosporidium infections. Cryptosporidium antigen comprised of a protein with or without carbohydrates attached thereto. Polyclonal and monoclonal antibodies directed against the antigen. DNA and RNA encoding the Cryptosporidium antigen, mutants, variants and fragments thereof.